Auckland, Issue 2, May 2013 Industry Newsletter
Auckland, Issue 3, July 2013
Synapse is Chiasma’s flagship event which will be held in the Owen G Glenn Building, Business School at The University of Auckland on August 8, 2013. Synapse is Chiasma’s premier event which attracts leading industry professionals, government representatives, university staff and students will be meeting to discuss key issues facing the New Zealand science and technology sector. Over the past ten years, Chiasma has had leading speakers from various hi-tech backgrounds who include Dr Sean Simpson (Founder and Chief Scientific Officer, Lanzatech), Professor Robert Elliott (Founder LCT), Brent Robinson (CEO Rakon), Sir Ray Avery (CEO Medicine Mondiale), Helen Anderson (Professional Director) , Michael Daniell (CEO Fisher and Paykel Healthcare) among many other notable members of New Zealand’s scientific community have inaugurated and attended this event. We are inviting you to attend at this premier event and join us in this process.
and Food Research, Life Technologies, Fisher and Paykel Healthcare, Orion Health, Bayer, Douglas Pharmaceuticals, Baldwins, MSI, Symansis, Alltech, Comvita, Via Lactia BIosciences among many other companies have helped them consider various career opportunities . This year, Synapse will be bigger and better. We are accepting 30 companies and we have organised an exciting line-up of speakers and with room for over 500 attendees, plenty of connections are bound to be made! If you are interested in attending, please click and register at synapse2013.co.nz
By attending your own stall at Synapse, you have the privilege, to interact with students, members of New Zealand’s scientific community and researchers based at The University of Auckland. Previous attendees have said that the insights gained from members of staff from the diverse companies that have exhibited which include Plant
Auckland, Issue 2, May 2013
scientifically savvy in order to succeed in todayâ€™s competitive science sector.
Science Commercialisation Workshop
27 July 2013
Douglas Manufacturing Site Visit 8 July 2013
The third workshop of our Careers Catalyst series featured two fantastic speakers, Hans van der Voorn from IZON Science based in Christchurch and Tim Stirrup, a patent attorney at Baldwins. IZON Science is a pioneering nanotechnology firm that has commercialised novel instrumentation to analyse particles at the nano-scale. As an engineer turned investor Hans was the CEO of Nova Gas till 2001, before his current role at Izon. Hans explained the chain-of-thought involved in developing and maintaining their suite of products which has wide ranging applications including drug delivery research, virus quantification and extracellular vesicles.
25 budding scientists braved the holiday blues and visited the Manufacturing plant of Douglas Pharmaceuticals based in Henderson in West Auckland.
Douglas Pharmaceuticals is a pioneering and rapidly expanding pharmaceutical company that was established in 1967 and produces tablets and capsules to a wide range of lotions, creams, suspensions for their product range and also undertake sub-contracting jobs and offer their expertise to their clientâ€™s product range and for their collaborative joint ventures. Services they provide include formulation, method transfer, validation, stability, quality assurance and quality control and has the skill base to package in bulk, bottles, blisters, pots and tubes. The site visit commenced with a brief safety review and attendees were introduced to Jeff and Chris who spoke about the extensive process of how a pharmaceutical drug makes its way onto the shelf and the time taken to synthesise the soft capsules which was by an extensive discussion on drug manufacturing, development and marketing and quality control that is stipulated by regulatory authorities.
Next up, we had Tim who explained how an idea can get patented and explained the difference between a patent, copyright and other ways one can protect their product. Tim took us on a journey highlighting the need to protect your precious idea and an overview of how intellectual property law can be applied to the biotechnology sector and numerous group discussions around the marketability and problems that need to be overcome in order to become world leaders in the field of nanomedicine.
Students were enthralled to see the inner workings of a manufacturing plant and the attention to detail needed to achieve high quality benchmarks. There was also a Q & A session followed by a networking session at their cafeteria.
This workshop provided attendees information on how businesses can undergo numerous stages of growth and development and how one needs to be commercially and
Read about our upcoming flagship event - Synapse; our workshop with Hans van der Voorn and Tim Stirrup; and our site visit to Douglas Pharma...